Literature DB >> 11520574

Analysis of p73 gene in meningiomas with deletion at 1p.

J Lomas1, M J Bello, D Arjona, P Gonzalez-Gomez, M E Alonso, J M de Campos, J Vaquero, P Ruiz-Barnes, J L Sarasa, C Casartelli, J A Rey.   

Abstract

The p73 gene has been mapped to 1p36.33, a chromosome region that is frequently deleted in a wide variety of neoplasms including meningiomas. The protein encoded by p73 shows structural and functional similarities to p53 and may thus represent a candidate tumor suppressor gene. To determine whether p73 is involved in the development of meningiomas, we examined 30 meningioma samples with proven 1p deletion for mutations of p73. Sequence analysis of the entire coding region of the p73 gene revealed previously reported polymorphisms in eight cases. A tumor-specific missense mutation as a result of an A-to-G transition with an Asn204Ser change was found in one meningioma that nevertheless retained the normal allele. These results suggest that if p73 plays a role in meningioma carcinogenesis, it must be in a manner different from the Knudson two-hit model.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11520574     DOI: 10.1016/s0165-4608(01)00430-7

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  8 in total

1.  Recurrent cytogenetic aberrations in histologically benign, invasive meningiomas of the sphenoid region.

Authors:  Andrey Korshunov; Vasiliy Cherekaev; Ali Bekyashev; Regina Sycheva
Journal:  J Neurooncol       Date:  2006-07-19       Impact factor: 4.130

2.  Chromosome 1p36 and 22qter deletions in paraffin block sections of intracranial meningiomas.

Authors:  Zerrin Yilmaz; Feride Iffet Sahin; Basar Atalay; Ozlem Ozen; Hakan Caner; Murad Bavbek; Beyhan Demirhan; Nur Altinörs
Journal:  Pathol Oncol Res       Date:  2005-12-31       Impact factor: 3.201

3.  Diagnostic and prognostic significance of genetic regional heterogeneity in meningiomas.

Authors:  Wolfgang K Pfisterer; Nicole C Hank; Mark C Preul; William P Hendricks; Jeanette Pueschel; Stephen W Coons; Adrienne C Scheck
Journal:  Neuro Oncol       Date:  2004-10       Impact factor: 12.300

Review 4.  Pathology and molecular genetics of oligodendroglial tumors.

Authors:  Christian Hartmann; Wolf Mueller; Andreas von Deimling
Journal:  J Mol Med (Berl)       Date:  2004-10       Impact factor: 4.599

5.  Molecular biology of unreresectable meningiomas: implications for new treatments and review of the literature.

Authors:  Jay Jagannathan; Rod J Oskouian; Hian Kwang Yeoh; Dwight Saulle; Aaron S Dumont
Journal:  Skull Base       Date:  2008-05

6.  Genomic profiling of atypical meningiomas associates gain of 1q with poor clinical outcome.

Authors:  Darlene Gabeau-Lacet; David Engler; Sumeet Gupta; George A Scangas; Rebecca A Betensky; Fred G Barker; Jay S Loeffler; David N Louis; Gayatry Mohapatra
Journal:  J Neuropathol Exp Neurol       Date:  2009-10       Impact factor: 3.685

7.  Gene expression analysis of aberrant signaling pathways in meningiomas.

Authors:  Miguel Torres-Martín; Victor Martinez-Glez; Carolina Peña-Granero; Alberto Isla; Luis Lassaletta; Jose M DE Campos; Giovanny R Pinto; Rommel R Burbano; Bárbara Meléndez; Javier S Castresana; Juan A Rey
Journal:  Oncol Lett       Date:  2013-05-23       Impact factor: 2.967

Review 8.  Emerging Medical Treatments for Meningioma in the Molecular Era.

Authors:  Fares Nigim; Hiroaki Wakimoto; Ekkehard M Kasper; Linda Ackermans; Yasin Temel
Journal:  Biomedicines       Date:  2018-08-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.